Search For "hetero"
Bharat Biotech's intranasal heterologous booster dose likely to hit market
Updated : 3 years, 4 months ago IST
According to the company, the price of iNCOVACC will be Rs 900 for the private market and Rs 325 for supplies to the Government of India and State Governments.
Read More
NTAGI to discuss inclusion of Covovax in CoWIN portal as heterologous boos
Updated : 3 years, 4 months ago IST
The National Technical Advisory Group on Immunisation (NTAGI) is likely to meet soon to discuss inclusion of Covid vaccine Covovax on the CoWIN portal as a heterologous booster dose for adults to boost uptake of booster doses, said official sources.
Read More
DCGI recommends Covovax as heterologous booster dose
Updated : 3 years, 4 months ago IST
The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for those who have already taken two doses of Covishield or Covaxin.
Read More
Bharat Biotech's nasal Covid vaccine to be priced at Rs 800 for private an
Updated : 3 years, 5 months ago IST
Bharat Biotech's nasal COVID-19 vaccine iNCOVACC, which was given approval as a booster dose, will be priced at Rs 800 plus GST in private hospitals..
Read More
Hetero's 'Nirmacom' is world's first generic version of COVID-19 oral drug
Updated : 3 years, 5 months ago IST
Hyderabad (Telangana) [India], December 27 (ANI/PRNewswire): Hetero, India's leading pharmaceutical company with the widest global reach, today announced the receipt of World Health Organization Prequalification of Medicines Program (WHO PQ) approval for its generic version of COVID-19 oral
Read More
Bharat Biotech's nasal Covid vaccine for adults gets Centre's nod, to be a
Updated : 3 years, 5 months ago IST
Bharat Biotech's nasal vaccine - iNCOVACC has been approved by the Government of India and will be used as a heterologous booster dose for those above 18 years of age
Read More
Scientists from across world come together to fight pathogens
Updated : 3 years, 5 months ago IST
A three-day conference with the objective of advancing the understanding on therapeutics to tackle pressing diseases began on December 6 at Conference Center of the University of Delhi.
Read More
India-made iNCOVACC, world's first intra-nasal vaccine to receive approval
Updated : 3 years, 5 months ago IST
iNCOVACC, on Tuesday, became the world's first intra-nasal vaccine to receive both Primary series and Heterologous booster approval, Bharat Biotech International Limited (BBIL) announced
Read More
DCGI approves '5-arms intranasal hetrologous booster dose' for restricted
Updated : 3 years, 6 months ago IST
The Drugs Controller General of India (DCGI) has given approval to intranasal "Five Arms" booster dose for restricted use for COVID-19 patients, it is learnt.
Read More
DCGI's subject expert committee to hold discussion on 'Five Arms' intranas
Updated : 3 years, 6 months ago IST
DCGI has already given emergency use authorization (EUA) to BBIL for the intranasal vaccine. BBIL had in September this year applied for DCGI's approval for market authorization of its "Five Arms" intranasal heterologous booster dose, and it has now announced that iNCOVACC (BBV154) has re
Read More
Antano & Harini successfully conclude the 6-Day carnival of Personal E
Updated : 3 years, 8 months ago IST
Mumbai (Maharashtra) [India], September 16 (ANI/PNN): Co-creators of the trillion dollars' worth Excellence Installations industry and Legacy Accelerators, Antano & Harini successfully hosted their flagship Accelerate uP! event in Mumbai. Magically heterogenous & diverse, the excelle
Read More
Bharat Biotech applies for market authorisation from DCGI for five arms in
Updated : 3 years, 8 months ago IST
New Delhi [India], September 11 (ANI): Bharat Biotech has applied for market authorisation from the Drugs Controller General of India (DCGI) for intranasal heterologous booster, sources told ANI.
Read More